Revenue and Earnings - Revenue for Q1 2025 was 192.6million,adecreaseof23.7252.4 million in Q1 2024[5] - Net income for Q1 2025 was 28.6million,down44.551.6 million in Q1 2024, resulting in diluted earnings per share of 0.88[5]−Non−GAAPnetincomeforQ12025was33,784, a decrease of 38.7% compared to 55,234inQ12024[25]−GAAPdilutedEPSforQ12025was0.88, down 43.9% from 1.57inQ12024[25]−Non−GAAPdilutedEPSforQ12025was1.04, a decline of 38.1% from 1.68inQ12024[25]−ForQ22025,Axcelisexpectsrevenuesofapproximately185 million and GAAP earnings per diluted share of approximately 0.57[7]−ThecompanyexpectsGAAPdilutedEPSof0.57 for Q2 2025, with a non-GAAP diluted EPS forecast of 0.73[30]Margins−GAAPgrossmarginwas46.1184.0 million from 123.5millionattheendof2024,withnodebtreported[17]−Totaloperatingexpensesremainedrelativelystableat59.6 million compared to 59.5millioninthepreviousyear[15]−Axcelismaintainsastrongcashposition,withnetcashprovidedbyoperatingactivitiesat39.8 million for Q1 2025[19] Adjusted Metrics - Adjusted EBITDA for Q1 2025 was 39.5million,downfrom64.5 million in Q1 2024[5] - Adjusted EBITDA for Q1 2025 was 39,520,representinga38.964,545 in Q1 2024[28] - Non-GAAP operating income for Q1 2025 was 35,211,down42.360,770 in Q1 2024[25] Shareholder Actions - The company is actively repurchasing shares while continuing to invest in innovation and business growth[3] Restructuring Costs - Restructuring costs in Q1 2025 amounted to $1,149, primarily related to global cost-saving initiatives[25]